
Biotech Cuts: Moderna Trims 10% Workforce
Moderna’s Restructuring: A Strategic Pivot for Long-Term Success The Post-Pandemic Reality Moderna’s recent announcement of a 10% global workforce reduction marks a significant shift in the company’s trajectory. This decision, while difficult, is a strategic response to the evolving healthcare landscape. The COVID-19 pandemic catapulted Moderna into the global spotlight, but the post-pandemic world presents…